Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
| ▸ | PYGL | P06737 | 1/20 | 0.36 |
| ▸ | TGM2 | P21980 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22861299 | 0.92 | ALDH1A1 (0.54) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL11315832 | 0.81 | ZDHHC20 (0.50) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL8017853 | 0.81 | ZDHHC20 (0.46) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL8014476 | 0.80 | ZDHHC20 (0.53) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL22861295 | 0.80 | TSHR (0.46) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL8014861 | 0.79 | ZDHHC20 (0.62) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL106883 | 0.79 | TSHR (0.54) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL252047 | 0.78 | — | — | |
| SCHEMBL9069372 | 0.78 | ZDHHC20 (0.66) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL31224580 | 0.77 | TSHR (0.52) | TSHRALDH1A1MAPK1TDP1ZDHHC20 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120100097-A1 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | AHLSTROM CORPORATION (FI) | 2012-04-26 | — | — | US | disclosed |
| EP-2424487-A2 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | Ahlstrom Corporation (FI) | 2012-03-07 | — | — | EP | disclosed |
| WO-2010125239-A2 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | AHLSTROM CORPORATION (FI) | 2010-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120100097-A1 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | ALG1, CHIT1, MAN2A1 | TSHR 3945/4885ALDH1A1 1034/4885MAPK1 264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.